BUY NOW For Sale 70%!
buy viagra

What is biotech ciprofloxacin tablets used for

MS annual conference

MS annual conference


The annual conference of what is biotech ciprofloxacin tablets used for MS patients was held by the Actover Pharmacological company on Thursday,  September  31st, with 300 patients and their families at the conference hall of ESpinas hotel.


At the conference, which was held by Actover Pharmaceutical company, prominent professors of neurology, such as Dr. Seyyed Masoud Nabavi, Neurologist, Fellowship MS, Associate Professor of Shahed University of Medical Sciences and Director of the Neurology Center  , Dr. Roya Abolfazli, Neurologist, Fellowship MS and associate professor of Tehran University of Medical Sciences, and Dr. Akbar Soltanzadeh were present. 


Neuroscience and Professor of Tehran University of Medical Sciences delivered a speech on MS and its problems and responded the patients' questions in the Q & A session.


At the conference, topics such as the use of new, injectable and oral medicines in MS control, the place of traditional medicine or complementary medicine on the disease, MS prognosis, the effect of MS on fertility, pregnancy, lactation, drug use during pregnancy And lactation, the role of genetics in MS, marriage and MS, the dietary effect and appropriate supplements in patients, fatigue management strategies, sleep deprivation, depression, anger and appropriate exercise to help  MS patients were raised.

Then Dr. Majid Zahedi Rad, director of the Actover Medical Science Unit and Dr. Ali Etemad Rezaee, director of the clinical studies department of Actover Pharmaceutical company, responded to the patient's questions about the possible complications, the proper use and proper drugs for MS.

Educational advisers of nursing and consulting centers for interferon drugs participated in the conference, and in addition to answering the questions of patients and their families, they donated educational packages.


MS annual conference

9/2/2017
MS annual conference
MS annual conference

The 18th International Congress of Reproductive Biomedicine

The 18th International Congress of Reproductive Biomedicine



The 18th International Congress of Reproductive Biomedicine, the 13th International Congress on Stem Cells and the 12th Nursing Seminar on Reproductive Medicine, were held simultaneously on the 30th August  to 1st September  in conference hall of Milad Tower.


At the International Congress on Reproductive Medicine, the Actover Pharmaceutical Company also introduced new products in the field of women, including Drosbela, Drosbelin, Tansy and Levitude.

Scientific secretary of the conference, referring to the prevalence of infertility in the country, said: The eighteenth Congress was held with the goal of scientific exchange of reproductive medicine and focus on infertility and its treatment.


He also referred to main constituents such as, individual-based medicine in infertility, endometriosis, antioxidants and fertility, fertility in cancer patients, animal biotechnology, and failure in fertility treatment.


The 18th International Congress of Reproductive Biomedicine

9/2/2017
The 18th International Congress of Repro...
The 18th International Congress of Reproductive Biomedicine

The 16th Annual Conference of the Iranian Association of Pharmacists

 The 16th Annual Conference of the Iranian Association of Pharmacists


The 16th annual conference of the Iranian Association of Pharmacists about "Neurology, Psychosis and Addiction" was held by the Scientific Association of Pharmacists on 24th to 26th August in Razi International Congress Center.


The conference was attended by more than 40 pharmaceutical companies including Actover. Also Dr. Nobakht, head of the Health commission of the Islamic Consultative Assembly and a group of pharmacists participated in the conference.


At the three-day conference on the Day of Pharmacist, topics such as neuroscience foundations of neuropsychiatric disorders, therapies of depression and anxiety, and also the role of pharmacist in prescribing and rational use of it, anti-drug therapies in hospitalized patients, hypnotics, alcohol toxicity, and their acute and chronic effects, pharmacoepidemiology of neuropsychiatric drugs, addiction treatment protocols, psychiatric disorders related to neurodegenerative diseases and modern technologies in treatment of hypertension were raised.


The scientific secretary of the conference noted: due to the importance of neurological diseases, and also alcohol and drug abuse disorders, 16th annual conference of pharmacists dedicated to this topic.



 The 16th Annual Conference of the Iranian Association of Pharmacists

8/28/2017
The 16th Annual Conference of the Irani...
The 16th Annual Conference of the Iranian Association of Pharmacists

relaxation workshop and stress relief methods

 relaxation workshop and stress relief methods



Workshop about "Relaxation and Stress Reduction in MS Patients" aimed at enhancing the abilities of MS patients and stress management was held by Actover Company on Thursday, 24th August in theThirteenth Aban Hall of the University of Tehran.


In this one-day workshop, a large number of patients were treated with interferon medications from the Actover Pharmaceutical Company. In this workshop which co-sponsored by the chairman of the Faculty of Pharmacy of the University of Tehran, the training programs were taught in two parts of the relaxation methods, as well as the training of correct motor behaviors (by psychologist and motor behavior specialist) for MS patients. Topics such as the definition of stress, types of stress, stressors, methods for reducing stress, stress management, reduction of MS symptoms by using relaxation methods, stress relief techniques, and yoga exercises were introduced.


Among the points of this workshop “teaching the techniques of relaxation and stress reduction methods” was an interesting topic which patients who presented in the program were satisfied with it.

 relaxation workshop and stress relief methods

8/27/2017
relaxation workshop and stress relief...
relaxation workshop and stress relief methods

The 9th scientific conference of the general physician association

The 9th scientific conference of the general physician association


The 9th  scientific Conference of Iranian general physician association was held on  July  26th  to 28th in Razi convention center of Iran University of Medical Sciences.

At the 9th scientific conference of the general physician association, the Actover Pharmaceutical Company attended and introduced its new products.


This scientific conference was held with the presence of the IRI Medical Council, other medical associations and medical educational groups of the country, and also companies active in the field of medical and pharmaceutical products and equipment. The main topic was "Public medicine, the basis of presentation health services ", and topics such as medical laws, ethics and communication with patients, management of diabetic patients, nutritional and therapeutic use of supplements to treat obesity, weight loss and chronic diseases, the introduction of new skin care methods, were the conference headings which presented at the three-day conference.


The 9th scientific conference of the general physician association

8/1/2017
The 9th scientific conference of the gen...
The 9th scientific conference of the general physician association was held on A...

The 17th annual congress of Iranian dermatologist association

 The 17th annual congress of Iranian dermatologist association


The 17th annual congress of dermatology association was held on July  26th  to 28th with the presence of dermatologists and companies which are active in the field of dermatology, including the Actover Company, at the convention center of Olympic Hotel.


At the congress, the Actover Pharmaceutical Company attended as the only official representative of Alergan products, it introduced a variety of juvederm fillers.


At this annual congress, Dr. Mohammad Ali Nilforosh Zadeh, the head of the congress, Dr. Ali Asilian and Dr. Farhad Henjani, as the members of scientific community of congress, and number of experts from various countries, and also the head of European society of pediatric dermatology attended.


"At this annual congress, we have 40 scientific-educational workshops and several scientific lectures," said Golshani about the goals of holding the congress. In addition, Iranian and foreign companies active in the field of skin, hair and beauty products attended at this annual congress.


He added: "Establishing international relations with foreign partners, and working with scientific association active in the field of skin and beauty, and the full support of professional assistants are the goals that we are pursuing with this congress.


On the last day of the congress, Actover pharmaceutical company as one of the sponsors of celebrating the pioneers and dermatologists collaborated with dermatologist association.


 The 17th annual congress of Iranian dermatologist association

8/1/2017
The 17th annual congress of Iranian der...
The 17th annual congress of Iranian dermatologist association was held on Octobe...

Clotover, for stroke prevention in Atrial Fibrillation

Clotover, for stroke prevention in Atrial Fibrillation
Rivaroxaban with the brand name Clotover, will release by Actover pharmaceutical company soon.

Rivaroxaban with the brand name Clotover, will release by Actover pharmaceutical company soon.



Rivaroxaban (clotover) is a prescription medicine used to reduce the risk of stroke and blood clot (as a blood thinner) in people with atrial fibrillation, not caused by a heart valve problem.

Rivaroxaban (clotover) is also a prescription medicine used to treat deep vein thrombosis and pulmonary embolism, and to help reduce the risk of these conditions occurring again.


Adding a blood thinner is important because risk of stroke is 5 times higher in a patient with AFib.These patients are still at risk of a stroke even if they don’t have any symptoms.


Compared with other anticoagulants, the predictable effect of Rivaroxaban (clotover)  means that regular blood tests aren’t needed to see if it’s working, check your levels or change your medication dose. In clinical studies, involving more than 55000 people, regular blood monitoring was not required, so you don’t have to plan your schedule around a blood monitoring routine when you take Rivaroxaban (clotover).


Rivaroxaban has already been prescribed 24 million times in the US, and it is proven to work.

In the largest clinical study of DVT and PE ever conducted, it was proven effective in treating DVT and PE, and help to reduce the risk of these conditions happening again.


Note: Rivaroxaban (clotover) is a prescription medicine and you should not take it without consulting with doctor.


Clotover, for stroke prevention in Atrial Fibrillation

7/17/2017
Clotover, for stroke prevention in Atria...
clotover will release by actover soon

film making for “seeking for calmness” TV series in Actover

 film making for “seeking for calmness” TV series in Actover

In order to film making for “seeking for calmness” TV series, which is broadcasting from channel 5 of TV, between some pharmaceutical companies the factory of Actover was chosen.

In this TV series which includes 40 episodes, the director is Saeid Soltani, producer is Ali Ashtianipour, and famous actors are Mehdi Hashemi, Jamshid Mashayekhi, Dariush Farhang, Farshid Zarei, and also other talented actors and actresses who play roles on this TV series. This TV series is broadcasting on Thursdays and Fridays every week from channel 5 of TV. 

From some different locations in order to film making for this TV series, Actover factory was chosen.

The TV series named “seeking for calmness” is a social melodrama, which includes some meaningful concepts, such as moving towards national self-efficiency, and also some social challenges.


 film making for “seeking for calmness” TV series in Actover

7/25/2017
film making for “seeking for calmness”...
Actover is the chosen place for film making for “seeking for calmness” TV series

12th conference of pediatric gastrointestinal and hepatic diseases

12th conference of pediatric gastrointestinal and hepatic diseases


12th conference of “pediatric gastrointestinal and hepatic diseases” was organized by “Iranian Society of pediatric gastroenterology and hepatology” on July  5th  to 7th  in the conference hall of   “children’s medical center” Tehran, Iran.


12th conference of “pediatric gastrointestinal and hepatic diseases” was organized by “Iranian Society of pediatric gastroenterology and hepatology” on July  5th  to 7th  in the conference hall of   “children’s medical center” Tehran, Iran.



Actover pharmaceutical company also participated in that conference. Pediatric specialists and experts presented lectures on subjects like malnutrition, gastrointestinal and hepatic diseases in children. Latest achievements and scientific articles in the field of pediatric digestive system were also discussed.


This conference was held with the aim of preventing pediatric diseases. Without any doubt, studying new articles, taking part in scientific conferences and discussing new findings in pediatric health can lead to new effective treatments. 


12th conference of pediatric gastrointestinal and hepatic diseases

7/25/2017
12th conference of pediatric gastrointes...
12th conference of pediatric gastrointestinal and hepatic diseases

5th conference of food and dietary supplements

5th conference of food and dietary supplements


5th conference of food dietary supplements and the first symposium of workout supplements with the subject “the use of diet supplements in metabolic syndrome” was held on May  16 to 18, in international conferences center of Olympic hotel.


Around 25 percent of adults and 50 percent of people who are older than 60 have metabolic syndrome.  

This was warning which scientific executive of the conference noted. Based on these statistics, noticing the life style and make changes in order to improve personal health, are so important.

It seems that the best treatment for metabolic syndrome is a balanced diet which includes enough supplements. 

In this congress, Actover pharmaceutical company participated and  introduced its productions and its supplements under “Life Style” brand name.

Holding these conferences (with the purpose of informing people about effectiveness of supplements in preventing and curing metabolic syndrome and some chronic diseases) would be very beneficial and also would be helpful to leading the society towards health.


5th conference of food and dietary supplements

7/26/2017
5th conference of food and dietary suppl...
5th conference of food dietary supplements and the first symposium of workout su...

20th congress of urology

20th congress of urology



20th congress of urology was held  on May 23 to 25th in the conference hall of university of Shahid Beheshti.


Muhammad Zargar, the executive of 20th urology congress expressed that smoking and drug abuse can lead to bladder cancer. Also, individuals working in dyeing workplaces and in contact with chemical substances are more in danger of bladder cancer.


Early diagnosis is very important. Bladder cancer is common among men and women and hematuria is usually the first sign of illness which patients should notice it.

He also explained that bladder cancer is less common between Iranian women in comparison with foreign women due to lower the rate of cigarette smoking.


He added: Today kidney stone treatment has progressed a lot compared with 25 years ago, and now we can treat most cases with lithotripsy technique.


20th congress of urology

7/25/2017
20th congress of urology
20th congress of urology was held on May 23 to 25th

The 28th annual conference of “Iranian society of internal medicine”

The 28th annual conference of “Iranian society of internal medicine”


The 28th annual conference of “Iranian society of internal medicine” was held in “Iran university of medical sciences” on May 15th to 17th. 


In this congress the members of “Iranian society of internal medicine” and experts participated. 

In This congress which holds every year in May, more than 128 scientific papers, 56 oral papers presented, and also some papers were chosen as posters. 

Furthermore, the best research papers and three thesis were chosen in the closing day of congress.


The 28th annual conference of “Iranian society of internal medicine”

7/26/2017
The 28th annual conference of “Iranian s...
The 28th annual conference of “Iranian society of internal medicine” was held o...

The 12th dermatology congress

The 12th dermatology congress


Dermatology research center of Shahid Behesti university held the 12th congress under the title “The newest international articles and dermatology innovations” on April 19th.

In this congress which was held in the conference hall of Milad hospital, the best articles in the field of dermatology was chosen, and also 250 articles which were published in the authentic and scientific magazines in the field of skin diseases, cooperation of dermatology and pathology, and also  skin care which were include the newest procedures were revised. 


The 12th dermatology congress

7/29/2017
The 12th dermatology congress
The 12th dermatology congress was held in the conference hall of Milad hospital

The graphic designers of actover won awards in a Europian festival

The graphic designers of actover won awards in a Europian festival


The graphic designers of actover pharmaceutical company (for the first time) participated in the advertising contest of Europian festival named “Smile”, and they won awards.

More than 600 companies participated in that festival. The graphic designers of actover won 14 international awards in that contest. 

They won awards because of creative imagery, applying the best slogans, and also applying the sense of humor in producing the advertisements. Those advertisements were in the field of the advertisement of Actocold medicine, the advertisement of Actofen extra medicine and World heart day

Besides, Actover entitled to the “Best pharmaceutical advertisements”. Moreover, the graphic designers of Actover won prizes for studying in master’s degree (which worth 5000 euros), and PhD (worth 25000 euros). 


The graphic designers of actover won awards in a Europian festival

7/29/2017
The graphic designers of actover won aw...
The graphic designers of actover won awards in a Europian festival named "...

The 24th international neurology congress and clinical electrophysiology

The 24th international neurology congress and clinical electrophysiology


The 24th International Congress of Neurology and Clinical Electrophysiology was organized by the Iranian Association of Neuropsychiatricians with the presence of foreign and domestic experts at the Olympic Hotel in Tehran on May 2nd to 5th.

 

“The fever and seizure between the ages of 6 months and 6 years is one of the common problems among children. If there is only a fever, then we need to work to eliminate it, so we would  not have more problems after that" said Amir Hassan Habibi, secretary of scientific association of the congress. "If the high fever is not controlled, it can be dangerous and may cause seizure and other problems with the brain and nerves of children" he added.

The secretary of the 24th International Congress of Neurology and Clinical Electrophysiology said: "Reducing the oxygen supply to the baby's brain during mother's delivery can cause a baby's cerebral palsy and cause a lot of problems for her and her family, which is also another area of illness Neurology for children.

He stated that hemorrhagic headaches are dangerous, if they occur in the morning, or if children have vomiting before the headache, or even headaches which are not preceded by previous history or different from previous headaches in terms of time and severity can be dangerous.


Habibi added that headaches that accompanied with other symptoms include a one-way weakness of the body, reduced consciousness or physical activity, may be dangerous, requiring more serious and further investigation.


Scientific secretary of the 24th International Congress of Neurology and Clinical Electrophysiology, explained the reasons of increasing the incidence of migraine, said that there is no accurate statistics on this issue. Of course, due to the diagnosis and identification of this disease compared to the past, it is sometimes because of some problems, such as stress which make the status of migraines worse”. 


"The tumors, depending on where they are located in the brain, may show a variety of symptoms, such as organ weakness, personality disorder, vomiting, intracranial pressure, and asthma," he said. 


The 24th international neurology congress and clinical electrophysiology

7/30/2017
The 24th international neurology congre...
The 24th International Congress of Neurology and Clinical Electrophysiology was...

Official starting partnership with Merck

Official starting partnership with Merck

International congress on the development of pharmaceutical and medical industry of Iran, with effort of Actover Company and Tehran university cooperation, with participation of CEO and senior executives of the German pharmaceutical company Merck, on 14th June 2014,was held

Mrs.Nahaleh Naraghi  CEO of Actover began the congress with expressing the position of Iran in the pharmaceutical industry & predicted a shining future depends on cooperating with best companies around the world. Apart from Official starting partnership with Merck, she mentioned all agreements for original drugs technology transfers has done & Actover will start producing Glucophage under Merck license.

After Mrs. Naraghi, gastroenterologist and director of the research center for gastroenterology and liver Tehran University of medical sciences Dr. Reza Malek zadeh  had a review of molecular bases of metabolic syndrome & insulin resistance & place of metformin in the treatment of this syndrome   

Following the speech, goals & expectation of association in Iran & scientific and industrial potential of cooperating between two countries had mentioned by senior manager of Merck

After that, Dr. Kheyrollah Gholami professor of Tehran University of medical sciences & head of hospitals pharmacies, mentioned to the importance of pharmacovigilance & drugs side effects monitoring (drug safety) to protect patients & consumers 

Official starting partnership with Merck

10/16/2014
Official starting partnership with Merck
with effort of Actoverco Company and Tehran university cooperation, with partici...

TV program

TV program

Actover pharmaceutical specialists took part in a live TV show on 13th of June, concerning the recent achievements of MS medicine production in Iran.

Dr. Alinasr Naraghi (chemist) and Mrs Nahaleh Naraghi (ceo) began the program by introducing Actoverco as the leader producer of MS medicine in Iran. Dr naraghi emphasized that Actover’s success depends mainly on its cooperation with the pharmaceutical originators.

Also, the importance of the clinical trials done by Actover to improve the production of MS medicine was emphasized.

At the end of the program, Mrs Naraghi mentioned the aim of Actover to establish an ethical culture for patients to trust and use the products made inside the country.

TV program

6/14/2014
TV program
Actoverco pharmaceutical specialists took part in a live TV show

The 13th Iranian MS Congress

The 13th Iranian MS Congress



The 13th Iranian MS Congress was held on November 9 to 11, 2016 at the Olympic Hotel of Tehran.


With more than a decade of continuous activity and getting experience over the years, the MS Association, especially the last year's congress, started this year's thirteenth international congress with a more complete and dynamic approach. Undoubtedly, the new attitude is based not only on scientific principles and excellence, but also on the needs of the day for patients who are now a significant population.


Throughout the world, there are plans for understanding disease better, pathophysiology, cell recognition, basic cells, and relative control, and also it is important to involve these science in research teams that align with MS. Fortunately this process was evident in the thirteenth Congress.


The Actover Company has been working to improve the lives of MS patients for many years, with the import and production of interferon-medications. In addition, Actover Pharmaceutical Company is an active base for injection and relief for MS patients. You can visit www.msmarkaz.com for more information on activities in this section.


The 13th Iranian MS Congress

9/5/2017
The 13th Iranian MS Congress
The 13th Iranian MS Congress

The 15th Annual conference of the Iranian Association of Pharmacists

 The 15th Annual conference of the Iranian Association of Pharmacists

The 15th Annual conference of Iranian Association of Pharmacists was held  on August 24th to 26th, 2016 in Razi International Convention Center.


Pharmacists and patients participated in the conference with the medication approach. Interesting lectures were made by professors and leading physicians in psychiatry and pharmacotherapy.


Actover pharmaceutical company participated in the conference and introduced its latest pharmaceutical products.


 The 15th Annual conference of the Iranian Association of Pharmacists

9/6/2017
The 15th Annual conference of the Iran...
The 15th Annual conference of the Iranian Association of Pharmacists

The 15th International Women and Midwifery Congress

 The 15th International Women and Midwifery Congress



The 15th International Women and Midwifery Congress of Iran by the Department of Obstetrics and Gynecology of Tehran University of Medical Sciences and the full participation of Iranian Women and Midwifery Society from October 4th to 7th, 2016 were held at the Razi Congress Center.


The head of the congress, Dr. Ashraf Ale Yassin, thanked for the cooperation of pharmaceutical companies and equipment in the various academic and executive departments of the congress, which played a valuable role in the process, announced that the widespread welcome of dear colleagues from all over the country indicated that Value-giving is an effort that has been carried out over the year by the Congressional Committee, in an intimate manner and using past experiences.


 In addition to its ever-presently active presence, Actover pharmaceutical company, as a Golden Sponsor of the Congress, sought to improve the quality of the congress, and received a congratulatory ceremony at Royan Congress.


 The 15th International Women and Midwifery Congress

9/5/2017
The 15th International Women and Midwif...
The 15th International Women and Midwifery Congress

The 24 Congress of the Association of Orthopedic Surgeons

 The 24 Congress of the Association of Orthopedic Surgeons


The 24 Congress of the Association of Orthopedic Surgeons was held on September 26th to 30th, 2016 in the center of the international congresses of the Consulates.


In the past period of this congress, the orthopedic association has achieved significant achievements in the orthopedic community, which undoubtedly has had a striking implication". This was the message of the head of Society of Orthopedic Surgeons at the 24 Congress of the Association of Orthopedic Surgeons. 


This congress, which is the country's largest orthopedic scientific event and the most important conference of orthopedic community, is an excellent opportunity for visiting doctors and professors and exchanging new experiences. As a result, Actover pharmaceutical company has been offering its latest medical products and research in the same way as in previous years.


 The 24 Congress of the Association of Orthopedic Surgeons

9/5/2017
The 24 Congress of the Association of O...
The 24 Congress of the Association of Orthopedic Surgeons

The 18th National Congress on Cardiovascular Diseases

The 18th National Congress on Cardiovascular Diseases



The 18th National Congress on Cardiovascular Diseases was held at the Milad Tower Conferences Center from September 13th  to 16th, 2016.


This conference was held in the presence of a large number of cardiologists, and internists. It should be noted that many doctors from all over the world participated in this congress.


Actover was the second sponsor of the Congress, and presented its products in the field of heart, internal and hospital drugs.


The 18th National Congress on Cardiovascular Diseases

9/5/2017
The 18th National Congress on Cardiovasc...
The 18th National Congress on Cardiovascular Diseases

The 6th Symposium on Heart and Innovations

The 6th Symposium on Heart and Innovations



The 6th Symposium on Heart and Innovations and the Joint Conference on the Heart and Endocrine, Heart and Nerves, with the assistance of the members of the Center of endoscopic surgery and Iranian Atherosclerosis Association, leading professors of neurology and endocrine, and its executive staff, and the co-operation of cultural, scientific and Research was conducted at the Power Research Center.


At the conference the latest diagnostic, therapeutic and common diseases of the heart, nerves, endocrine glands and its related affairs were presented, and also specialized physicians and prominent cardiologists, nerves and endocrine experts from around the world spoke on common issues and new developments.


New issues such as strategies for reducing cardiovascular diseases, timely diagnosis and treatment of blood pressure, heart failure and its association with stroke and thyroid and new anticoagulant drugs, and new technology for treating heart disease, endocrinology, and many other issues, included the topics of the conference were presented.


It is hoped that the warm presence of the doctors and professors of the medical community in this conference and future congresses will be the continuation of the scientific and research activities of the medical associations and the growth and advancement of our beloved country.


The 6th Symposium on Heart and Innovations

9/5/2017
The 6th Symposium on Heart and Innovatio...
The 6th Symposium on Heart and Innovations

The 19th Iranian Urology Congress

The 19th Iranian Urology Congress



The 19th Iranian Urology Congress was held in the Aboureyhan Hall of Shahid Beheshti University, on August 23rd to 26th, 2016. 


The large number of most prominent urologists from the cities of Isfahan, Shiraz, Bandar Abbas, Kerman and Kermanshah came to Tehran to attend the congress, and also there were many specialists from Bangladesh, Morocco, Germany, Netherlands who presented at the congress.


Actover Pharmaceutical Company participated in the congress for the first time and introduced specialized urological drugs such as Tamsover, Lectrum, Vizarsin and Cyproterone Acetate.


The 19th Iranian Urology Congress

9/6/2017
The 19th Iranian Urology Congress
The 19th Iranian Urology Congress

The 2nd Iranian Congress of Nephrology and Urology

The 2nd Iranian Congress of Nephrology and Urology



The 2nd Iranian Congress of Nephrology and Urology was held on August 1th to 4th, 2016 at the Razi Hall of Milad Tower.


The Congress was conducted with the aim of integrating two associations of nephrology and urology with the invitation of experienced doctors from all over the country. The Actover Company was the sponsor of 10 physician from all over the country. In the conference hall booth of Actover, medicines, such as Suprimun and Tomsover were presented to the neurology group, and Lectrum presented to urologists group.


The 2nd Iranian Congress of Nephrology and Urology

9/6/2017
The 2nd Iranian Congress of Nephrology a...
The 2nd Iranian Congress of Nephrology and Urology

Launch ceremony of Emozul

Launch ceremony of Emozul



The launch ceremony of new medicine named Emozol was held by Actover pharmaceutical company on May 5th, 2016 at Espinas Palace hotel. 


Actover pharmaceutical company with more than 40 years of experience in the field of pharmacy, always try to develop and produce the prescription products which are needed for society.


With this approach, on May 5th, 2016, Espinas Palace Hotel was the venue for the launch of Emozol. The event was attended by the top gastroenterologist such as Professor Ebrahimi Daryani, Prof. Mehdi Saberi Firoozi and Professor Masoudi.


After the introduction of this drug, the activities of the pharmaceutical factory and its manufacturing sites were addressed to physicians.


Launch ceremony of Emozul

9/6/2017
Launch ceremony of Emozul
Launch ceremony of Emozul

The first Symposium on Heart & Brain

The first Symposium on Heart & Brain



The first Symposium on Heart & Brain was held on Friday, 29th April, 2016 by Actover pharmaceutical company.


The symposium was held in presence of a large number of neurologists, cardiologists, vascular surgeons, heart electrophysiologists, echoscopy specialists and heart surgeons.The event was held at Espinas Palace Hotel with support of Association of Atherosclerosis, neurological, stroke and cardiology institute in order to register this day as an annual event.


The scientific symposium had two sections of the scientific treatment and diagnosis of strokes with unknown cause. Dr. Masoud Eslami provided slides and important point of view about patients with stenosis Over 90% of carotid arteries.


Dr. Iraj Ghoddoosi, the vascular surgeon, at the end of the symposium gave a lecture about interesting cases of surgery in the stenosis of 90% of carotid arteries. Dr. Seyfollah Abdi, an intronsion specialist, also had an interesting case presentation, and eventually, after a Q & A session, the one-day conference ended.


Actover hopes to continue this year's symposium with the help and cooperation of other associations dedicated to Heart & Brain in the coming years, with the goal of developing scientific discussions.


The first Symposium on Heart & Brain

9/6/2017
The first Symposium on Heart & Brain
The first Symposium on Heart & Brain

German Economic entity visited Actover Pharmaceutical Factory

German Economic entity visited Actover Pharmaceutical Factory



Minister of Economic Affairs of the Hessen Province of Germany, headed by the Economic Council, visited Actover Pharmaceutical company on September 18th, 2016.


He estimated the capacities and the possibility of cooperation with Iran in various industrial and commercial.

During the visit, Dr. Akbar Abdollahi Asl, Director of surveillance on Food and Drugs of Ministry of Health, provided a complete report of Iranian pharmaceutical industry, opportunities and barriers to manufacturing medicines and foreign investors, so their transparency and honesty were welcomed and encouraged by the German authorities.


Tareq al-Wazir, the Hessen Economics Department of Germany, also visited the various parts of the Actover pharmaceutical company, and also spoke about cooperation between Merck and Actover and Merck’s  commitment to the Iranian market since 2001, and even in The 10-year sanctions period in the region. He also note: “this pharmaceutical company, is the world's oldest pharmaceutical and chemical company, is transferring the major technology of treatment MS through the rebif drug.


Eric Nobis, a senior executive at Merck in Europe, the Middle East, and Africa, said: "Our partnership with the Iranian side gives millions of patients access to high quality drugs for treat of type 2 diabetes, cardiovascular disease and thyroid disorders." At the moment, we are very pleased that we are looking at the new developments in product line of Nurobion for consumer health in the field of neurological medical care.


He pointed out that Actover Pharmacy Company behold of Merck has been working on production of diabetics medicines called Glucophage, as well as Nurobion which is an neurological medicine. In the near future, the technology to produce an oncological drug for treat cardiovascular diseases named Concor, and also Euthyrox for treat of thyroid disorders, Glucophage XR for treat type 2 diabetes and Rebif to treat. We will complete S & T, and Merck will become the first multinational company to transfer biotechnology knowledge in Iran.


Nahaleh Naraghi, Managing Director of Actover Pharmaceutical company stated: "As the owner of Merck company in Iran, we can provide the medicines needed by clients and patients as soon as possible and at the lowest cost. Merck is now committed to develop its activities in Iran, which will lead to access the high standards products in pharmaceutical industry".

The economic entity with 40 members headed by Tariq al-Wazir Hessen's finance minister, traveled to Iran, is the first state-owned economic entity which traveled to Iran after ten years with the country's finance minister.


The purpose of traveling the German economic entity is expanding the economic relations with countries like Iran which are in the path of industrialization. Based on this, it is planned to examine the first steps for economic development. The economic relations between the Hessen state of Germany and the Iranian government, which had fallen sharply due to economic sanctions against Iran, are scheduled to resume on this visit, and new economic relations will be reviewed and implemented.


The Hessen State Partnership Agreement was signed with the Chamber of Commerce and Industry of Iran, a review of cooperation in banking affairs, the submission of the necessary parts of Germany for the automotive industry in Iran, and cooperation in the field of pharmaceutical industry from the trips of the Minister of Economic Affairs of the State of Hessen to Germany.


Although since January 2016, the Hessen state has increased its exports to Iran by 15%, the state's export rates have not yet reached Iran before sanctions. Economic ties between Germany and Iran have increased dramatically since the end of the sanctions, with Germany's exports to Iran rising by 15 percent to € 100 billion in the first half of this year (2016).


According to the managing director of the Chamber of Commerce and Industry of Germany and Iran, Germany's exports to Iran will increase by 20-25% in the second half of 2016. Iran's trade relations with other states of Germany are also increasing.


German Economic entity visited Actover Pharmaceutical Factory

9/5/2017
German Economic entity visited Actover P...
German Economic entity visited Actover Pharmaceutical Factory

The 3th National Congress and the First International Congress on Endometriosis and Women's Low-Aggression Surgery

The 3th National Congress and the First International Congress on Endometriosis and Women's Low-Aggression Surgery



The Third National Congress and the First International Congress on Endometriosis and Women's Low-Aggression Surgery from November 25th-27th, in Abureyhan Hall, International Center of Shahid Beheshti University, and by the New Bioscience Research Institute of Ebnecina Jahad Daneshgahi, Center for Endometriosis and Women's Low-Aggression Surgery of England.


Various aspects of the congress were discussed, most notably:

• Diagnosis and classification of endometriosis and its medical treatment

• Low invasive surgery and endometriosis, training and commissioning

• Need for low-invasive surgery

• Endometriosis and fertility

• Surgical treatments in endometrium and myometectomy

• The role of minimally invasive surgery in women's urology and oncology in women 

• Nursing in less intrusive surgery

• The role of midwife in the diagnosis and referral of patients with endometriosis

• Pathogenicity

• Environmental factors

• Non-invasive methods of diagnosis and screening

• Genetics, Epigenetics and Hereditary Aspects

• Quality of Life


With regard to the main congressional issues, this congress would be worthwhile and more attention will be devoted to the coming years. With this approach, we hope to be able to contribute to the richness of the content and supply of pharmaceutical products.


The 3th National Congress and the First International Congress on Endometriosis and Women's Low-Aggression Surgery

9/5/2017
The 3th National Congress and the First...
The 3th National Congress and the First International Congress on Endometriosis...

Blood Transfusion Day

Blood Transfusion Day


Blood Transfusion Day is on July 31st, Anniversary of the establishment of the Blood Transfusion Organization of Iran


July 31st is the day of blood transfusion in Iran. Dr. Fereydoun Ala was the founder of the Blood Transfusion Organization of Iran.The Iranian Blood Transfusion Organization was established on July 31st1974, with the aim promoting the culture of donation and supplying safe blood to meet the needs of patients, especially those with thalassemia, hemophilia, and Leukemia. The anniversary of the organization's foundation on July 31st is named as a blood donation day. 


Blood Transfusion Day

9/6/2017
Blood Transfusion Day
Blood Transfusion Day

The 2nd Iranian Congress of Nephrology and Urology

The 2nd Iranian Congress of Nephrology and Urology



The 2nd Iranian Congress of Nephrology and Urology was held on August 1th to 4th, 2016 at the Razi Hall of Milad Tower.


The Congress was conducted with the aim of integrating two associations of nephrology and urology with the invitation of experienced doctors from all over the country. The Actover Company was the sponsor of 10 physician from all over the country. In the conference hall booth of Actover, medicines, such as Suprimun and Tomsover were presented to the neurology group, and Lectrum presented for the urologists group.


The 2nd Iranian Congress of Nephrology and Urology

9/6/2017
The 2nd Iranian Congress of Nephrology a...
The 2nd Iranian Congress of Nephrology and Urology

Contract with the Swiss Chemo company for producing hormonal medicines

 Contract with the Swiss Chemo company for producing hormonal medicines


The ceremony for the signing a contract for the production of hormonal drugs in Iran, with the presence of Dr. Dinarwand, Deputy Minister of Health, Dr Jamshidi, Managing Director of the Blatter Pharmaceuticals and Ignacio Penco Board Member of Chemo Company, was held on March 14th, 2016 between the Blatter Pharmaceutical Group and the Swiss Como Company.


CHEMO company of Switzerland is one of the largest generic drug manufacturers in Europe, with 65 percent investment in one of the Pharmaceutical company of who were ready to sign up for investment in Iran. The result of the investment, which in the first phase was more than $ 15 million, is the complement of chain of raw materials for producing the medicines in the country.
The partnership for “Barekat” Pharmacy Group and the Iranian Pharmaceutical Industry will bring international knowledge and promote the quality and quantity of pharmaceutical products and international standards. The Swiss-Spanish International Company offered over 500 items of medicine in a range of therapeutic areas in 40 countries with 11 modern factories, 9 research centers and 30 affiliated pharmaceutical companies and products in four continents.


By signing this contract, export between Atipharmed Pharmaceutical Company and Chemo will be expand in the future, and also raise the level of knowledge of managers and experts.


 Contract with the Swiss Chemo company for producing hormonal medicines

9/6/2017
Contract with the Swiss Chemo company f...
Contract with the Swiss Chemo company for producing hormonal medicines


Source: http://www.actoverco.com/


BUY NOW For Sale 70%!
buy viagra

List of medicinal products authorised under Article 126a Traumanase forte dosierung ciprofloxacin

What is biotech ciprofloxacin tablets used for BF-30 effectively inhibits ciprofloxacin-resistant
What is biotech ciprofloxacin tablets used for Biodegradation of ciprofloxacin by white rot
What is biotech ciprofloxacin tablets used for MYCOPHENOLATE MOFETIL CAPSULES TABLETS
What is biotech ciprofloxacin tablets used for Actoverco - Official Website
What is biotech ciprofloxacin tablets used for Bayer - Wikipedia
(Oxnard, California) - Reverse Phone Antibiothrapie des infections ostoarticulaires pyognes Buy FLAGYL Online (Metronidazole Generic) Cached Chronic cold - Cold Flu - MedHelp Cipro Uses, Dosage Side Effects - m
BUY NOW For Sale 70%!
buy viagra